MedTrace Logo

Markers of Oxidative Stress in a Early Week Miscarriage: Ischemia of Modified Albumin

NCT01988740 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2013-11-20

No results posted yet for this study

Summary

The finding that ischemia-modified albumin (IMA) is increased in pre-eclamptic pregnancy suggests a role for IMA as a potential biomarker for abnormal placental development related to miscarriage.This study was undertaken to evaluate IMA levels in women with recurrent pregnancy loss (RPL).

Conditions

  • First Trimester Pregnancy
  • Fetal Heart Activity Absent
  • Absence of Fetal Pole on Ultrasonographic Examination.

Sponsors & Collaborators

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    lead OTHER_GOV

Principal Investigators

  • hüseyin cengiz, md · Bakırkoy Dr. Sadi Konuk Training and Research Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-03-31
Completion
2014-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01988740 on ClinicalTrials.gov